NO20073287L - 2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorer - Google Patents
2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorerInfo
- Publication number
- NO20073287L NO20073287L NO20073287A NO20073287A NO20073287L NO 20073287 L NO20073287 L NO 20073287L NO 20073287 A NO20073287 A NO 20073287A NO 20073287 A NO20073287 A NO 20073287A NO 20073287 L NO20073287 L NO 20073287L
- Authority
- NO
- Norway
- Prior art keywords
- benzazole
- disubstituted
- analogs
- protein kinase
- kinase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Foreliggende oppfinnelse angår forbindelser av generelle formler (I), (Ia) og (II) og salter og fysiologisk funksjonelle derivater derav, hvori substituentene -Y er bundet til 5- eller 6-stillingen av benzazolet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04030819A EP1674466A1 (en) | 2004-12-27 | 2004-12-27 | 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
PCT/EP2005/013922 WO2006069740A1 (en) | 2004-12-27 | 2005-12-22 | 2, 5 and 2, 6-disubstituted benzazole analogues useful as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073287L true NO20073287L (no) | 2007-09-25 |
Family
ID=34928006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073287A NO20073287L (no) | 2004-12-27 | 2007-06-27 | 2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorer |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1674466A1 (no) |
JP (1) | JP5302540B2 (no) |
CN (1) | CN101090899B (no) |
AU (1) | AU2005321517B2 (no) |
BR (1) | BRPI0519479A2 (no) |
CA (1) | CA2592509C (no) |
EA (1) | EA013863B1 (no) |
IL (1) | IL184266A (no) |
MX (1) | MX2007007897A (no) |
NO (1) | NO20073287L (no) |
NZ (1) | NZ555303A (no) |
SG (1) | SG178717A1 (no) |
UA (1) | UA92730C2 (no) |
WO (1) | WO2006069740A1 (no) |
ZA (1) | ZA200704313B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1674467A1 (en) * | 2004-12-22 | 2006-06-28 | 4Sc Ag | 2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors |
KR20100017866A (ko) | 2007-05-21 | 2010-02-16 | 노파르티스 아게 | Csf-1r 억제제, 조성물 및 사용 방법 |
FR2922550B1 (fr) * | 2007-10-19 | 2009-11-27 | Sanofi Aventis | Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet |
FR2933982A1 (fr) * | 2008-07-18 | 2010-01-22 | Sanofi Aventis | Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met |
FR2933980B1 (fr) * | 2008-07-18 | 2011-07-29 | Sanofi Aventis | Nouveaux derives triazolo°4,3-a!pyridine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met |
FR2933981A1 (fr) * | 2008-07-18 | 2010-01-22 | Sanofi Aventis | NOUVEAUX DERIVES IMIDAZO°1,2-a!PYRIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET |
WO2010010435A2 (en) * | 2008-07-22 | 2010-01-28 | Glenmark Pharmaceutical S.A. | Fused oxazole and thiazole derivatives as trpms modulators |
WO2011033094A1 (en) | 2009-09-18 | 2011-03-24 | 4Sc Ag | Schedule of administration of benzazole derivatives in the treatment of leukemias |
RU2632900C2 (ru) | 2010-11-19 | 2017-10-11 | Лиганд Фармасьютикалс Инкорпорейтед | Гетероциклические амины и их применение |
ES2592404T3 (es) | 2012-05-21 | 2016-11-30 | Bayer Pharma Aktiengesellschaft | Benzotienopirimidinas sustituidas |
TW201412740A (zh) | 2012-09-20 | 2014-04-01 | Bayer Pharma AG | 經取代之吡咯并嘧啶胺基苯并噻唑酮 |
US10807983B2 (en) | 2015-03-16 | 2020-10-20 | Ligand Pharmaceuticals, Inc. | Imidazo-fused heterocycles and uses thereof |
KR20180088113A (ko) * | 2017-01-26 | 2018-08-03 | 한미약품 주식회사 | 이미다조피리다진 화합물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9900752D0 (en) * | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
AU2002232439A1 (en) * | 2000-11-29 | 2002-06-11 | Glaxo Group Limited | Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
ES2290479T3 (es) * | 2002-03-01 | 2008-02-16 | Smithkline Beecham Corporation | Diamino-pirimidinas y su uso como inhibidores de la angiogenesis. |
DE60329910D1 (de) * | 2002-03-29 | 2009-12-17 | Novartis Vaccines & Diagnostic | Substituierte benzazole und ihre verwendung als raf-kinase-hemmer |
US7531553B2 (en) * | 2003-03-21 | 2009-05-12 | Amgen Inc. | Heterocyclic compounds and methods of use |
SI2392564T1 (sl) * | 2003-09-26 | 2014-02-28 | Exelixis, Inc. | c-Met modulatorji in postopki uporabe |
WO2005073224A2 (en) * | 2004-01-23 | 2005-08-11 | Amgen Inc | Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer |
-
2004
- 2004-12-27 EP EP04030819A patent/EP1674466A1/en not_active Withdrawn
-
2005
- 2005-12-22 CA CA2592509A patent/CA2592509C/en not_active Expired - Fee Related
- 2005-12-22 UA UAA200707229A patent/UA92730C2/ru unknown
- 2005-12-22 MX MX2007007897A patent/MX2007007897A/es active IP Right Grant
- 2005-12-22 JP JP2007547375A patent/JP5302540B2/ja not_active Expired - Fee Related
- 2005-12-22 NZ NZ555303A patent/NZ555303A/en not_active IP Right Cessation
- 2005-12-22 EP EP05824907A patent/EP1833823A1/en not_active Withdrawn
- 2005-12-22 BR BRPI0519479-2A patent/BRPI0519479A2/pt not_active IP Right Cessation
- 2005-12-22 SG SG2012004024A patent/SG178717A1/en unknown
- 2005-12-22 CN CN200580045091.XA patent/CN101090899B/zh not_active Expired - Fee Related
- 2005-12-22 EA EA200700997A patent/EA013863B1/ru not_active IP Right Cessation
- 2005-12-22 AU AU2005321517A patent/AU2005321517B2/en not_active Ceased
- 2005-12-22 WO PCT/EP2005/013922 patent/WO2006069740A1/en active Application Filing
-
2007
- 2007-05-25 ZA ZA200704313A patent/ZA200704313B/xx unknown
- 2007-06-27 NO NO20073287A patent/NO20073287L/no not_active Application Discontinuation
- 2007-06-27 IL IL184266A patent/IL184266A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101090899A (zh) | 2007-12-19 |
MX2007007897A (es) | 2008-01-11 |
EA013863B1 (ru) | 2010-08-30 |
AU2005321517A1 (en) | 2006-07-06 |
EP1833823A1 (en) | 2007-09-19 |
JP2008525361A (ja) | 2008-07-17 |
IL184266A0 (en) | 2007-10-31 |
WO2006069740A1 (en) | 2006-07-06 |
NZ555303A (en) | 2010-01-29 |
UA92730C2 (ru) | 2010-12-10 |
SG178717A1 (en) | 2012-03-29 |
CN101090899B (zh) | 2015-09-09 |
AU2005321517B2 (en) | 2011-09-29 |
CA2592509C (en) | 2015-02-17 |
IL184266A (en) | 2013-04-30 |
JP5302540B2 (ja) | 2013-10-02 |
EP1674466A1 (en) | 2006-06-28 |
EA200700997A1 (ru) | 2007-12-28 |
BRPI0519479A2 (pt) | 2009-02-03 |
CA2592509A1 (en) | 2006-07-06 |
ZA200704313B (en) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073287L (no) | 2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorer | |
NO20066055L (no) | Pyridinderivater | |
NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
NO20070336L (no) | Indolderivater som histamin-reseptorantagonister | |
NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
NO20070249L (no) | Pyrrazolo-pyrimidin derivater | |
NO20080391L (no) | Pyrazolbaserte LXR modulatorer | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
NO20050007L (no) | 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander | |
NO20071593L (no) | Pyrimidinderivater | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
PL1899329T3 (pl) | Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych | |
NO20084489L (no) | Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
NO20076460L (no) | Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
NO20050014L (no) | 1-Heterosyklylalkyl-3-sulfonylindol eller -indazolderivater som 5-hydroksytryptamin-6 ligander | |
NO20085257L (no) | Purinonderivater som HM74a-agonister | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |